Credit: CC0 Public Domain COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death, according to a new study. However the research, from over 4000 pregnant women with suspected or confirmed COVID-19, also found women who had a positive test were more likely to have a premature birth. The research, led by…
Medical
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The US Food and Drug Administration (FDA) on Monday updated its October guidance for manufacturers developing COVID-19 vaccines, diagnostics, and treatments in the wake of circulating SARS-CoV-2 variants. The United States is currently facing three main variant threats, according to the…
It's the national record no one is celebrating: The American COVID-19 death toll has crossed the 500,000 mark. The novel coronavirus is now the third leading cause of death in the U.S. — behind heart disease and cancer, but ahead of accidents, respiratory diseases, stroke, Alzheimer's, and the flu, according to annualized federal health statistics. COVID-19 deaths have also surpassed the number…
Data from an observational cohort study suggest that the presence of abandoned leads in patients with cardiac implantable electronic devices (CIEDs) should no longer be an absolute contraindication to MRI. In the study, which spanned 7 years and included 139 consecutive patients, adverse events were few, mild, and transient. The results were published online February…
A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) warning of cardiac risk in patients taking the antiseizure drug lamotrigine. The task force is concerned that the FDA warning is based on data…
Not every cancer drug approved by the FDA receives approval and coverage in England and Canada, two studies in JAMA Internal Medicine showed. In England, a retrospective cohort study looked at 68 drugs given accelerated approval by the FDA from December 1992 to May 2017 that also received market approval in the European Union. The…
COVID-19 vaccines modified to work against circulating virus variants should have clinical immunogenicity studies supporting their effectiveness, and ensure they work not only against the variant strain, but the initial strain, the FDA said in modified guidance on Monday. Manufacturers will also need to conduct booster studies, where the modified vaccine is given to those…
The U.S. may have fewer coronavirus cases than in recent weeks, but the situation is still grim: The country is expected to hit 500,000 confirmed COVID-19 deaths today, just a month after it counted 400,000.As of this writing, there have been 499,902 confirmed COVID-19 deaths in the U.S., according to data from the Johns Hopkins…